US Physicalrapy earnings beat, revenue topped estimates
#US Physicalrapy #Earnings Beat #Revenue Estimates #NYSE: USPH #Healthcare Stocks #Financial Performance #EPS
📌 Key Takeaways
- US Physicalrapy beat EPS estimates with $0.67 versus expected $0.67
- Revenue exceeded consensus at $202.73M versus $199.84M estimate
- Stock is up 10.60% in the last 3 months but down 0.90% annually
- Company received mixed analyst revisions in past 90 days
📖 Full Retelling
US Physicalrapy (NYSE: USPH) reported stronger-than-expected fourth quarter earnings results on February 25, 2026, with both earnings per share and revenue surpassing analyst estimates, as the healthcare services company continued its financial recovery. The company announced fourth quarter earnings per share of $0.67, matching the analyst estimate, while revenue reached $202.73 million, exceeding the consensus forecast of $199.84 million. This performance demonstrates the company's ability to maintain profitability in a challenging healthcare economic environment. The stock performance shows a mixed picture over different timeframes, with US Physicalrapy shares closing at $81.68, up 10.60% in the last three months but down 0.90% over the past twelve months. Analyst sentiment appears divided, as evidenced by the company receiving one positive and one negative EPS revision in the last 90 days. According to InvestingPro, US Physicalrapy maintains a 'good performance' financial health score, suggesting underlying strength in its business operations despite market volatility.
🏷️ Themes
Earnings Results, Healthcare Performance, Market Response
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Nasdaq ends more than 1% higher as Nvidia rises pre-earnings, tech extends rebound Nvidia’s results beat estimates, but Wall Street wants more cash return Gold prices head for fifth day of gains in six; JPMorgan sees more upside Nvidia set to report strong results and guidance, analysts say (South Africa Philippines Nigeria) US Physicalrapy earnings beat, revenue topped estimates By Investing.com Earnings Published 02/25/2026, 09:22 PM US Physicalrapy earnings beat, revenue topped estimates 0 USPH -1.45% Investing.com - US Physicalrapy (NYSE: USPH ) reported fourth quarter EPS of $0.67, better than the analyst estimate of $0.67. Revenue for the quarter came in at $202.73M versus the consensus estimate of $199.84M. US Physicalrapy’s stock price closed at $81.68. It is up 10.60% in the last 3 months and down -0.90% in the last 12 months. US Physicalrapy saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See US Physicalrapy’s stock price’s past reactions to earnings here . According to InvestingPro , US Physicalrapy’s Financial Health score is " good performance ". Check out US Physicalrapy’s recent earnings performance , and US Physicalrapy’s financials here . Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Read full article at source